We studied a quantitative electroencephalographic (EEG) measure, coher
ence, in 28 patients with acquired immune deficiency syndrome (AIDS) a
nd 56 uninfected volunteers. Compared with uninfected subjects, AIDS p
atients had increased coherence in the 6- to 10-Hz band. The largest i
ncreases in coherence were between frontal and occipital regions and b
etween temporal and frontal regions. Coherence within contiguous regio
ns was less affected. Eight of the 28 AIDS patients (29%) had clinical
ly abnormal EEG findings, compared with four of the 56 uninfected cont
rol subjects (7%). Among the AIDS patients, 12 had normal neuropsychol
ogical performance, nine had mild impairment, and six had moderate imp
airment. Coherence was increased in each subgroup of AIDS patients, in
cluding those with normal neuropsychologic performance and/ or normal
clinical EEG results. AIDS patients were then classified by quantitati
ve EEG power in frontal head regions as ''abnormal'' (the upper third
of patients) or ''normal'' (the remainder). Increased coherence was fo
und among both groups. Because the development of abnormal neuropsycho
logical performance or a clinically abnormal EEG examination indicates
relatively advanced central nervous system disease, alterations in sp
ecific coherence measures may detect subclinical effects of the human
immunodeficiency virus on brain function before other changes are evid
ent.